S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
Condition(s):Multiple MyelomaLast Updated:March 6, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:March 6, 2015Completed
Condition(s):Chronic Myelogenous Leukemia; Malignant Melanoma; Renal Cell CarcinomaLast Updated:January 9, 2017Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 24, 2014Terminated
Condition(s):HLA-A2 Positive Cells Present; Refractory MelanomaLast Updated:January 30, 2024Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:May 5, 2015Completed
Condition(s):MelanomaLast Updated:May 3, 2017Completed
Condition(s):Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:July 24, 2014Completed
Condition(s):Diffuse Intrinsic Pontine GliomaLast Updated:February 13, 2012Completed
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 1, 2013Completed
Condition(s):Rectal CancerLast Updated:February 2, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.